Soma Pain 350mg (Carisoprodol) – UK Safety Information

Soma Pain 350mg is a tablet product presented as containing 350mg of carisoprodol, a centrally acting muscle relaxant. Soma Pain 350mg has been used in some countries for short-term relief of discomfort associated with acute, painful musculoskeletal conditions. It is not a sleeping tablet and should not be promoted as a general painkiller, relaxation product or long-term treatment.

The UK position is especially important. Carisoprodol marketing authorisations were withdrawn in the UK after regulators concluded that the risks of abuse, addiction, intoxication and psychomotor impairment outweighed the benefits. The latest official UK review also states that carisoprodol remains an unlicensed medicine and that there are no legitimate human or veterinary uses for it in the UK.

For that reason, Soma Pain 350mg should be presented as an educational safety page rather than a routine UK product available for unrestricted online purchase.

What Is Soma Pain 350mg?

Soma Pain 350mg is described as an oral tablet containing carisoprodol. Carisoprodol acts within the central nervous system and is metabolised in the liver to meprobamate, another psychoactive sedative substance.

In countries where carisoprodol remains authorised, it may be prescribed alongside rest, physical therapy and other measures for short-term discomfort associated with acute muscle injuries. This does not mean the product is authorised for ordinary sale or prescribing in the UK.

The product should never be confused with:

• A sleeping medicine
• An opioid painkiller
• A treatment for long-term back pain
• A treatment for anxiety
• A medicine for neurological spasticity
• A product suitable for self-diagnosis

UK Licensing and Regulatory Position

The European medicines regulator recommended suspending marketing authorisations for carisoprodol-containing medicines after finding evidence of abuse, addiction, intoxication and impaired movement or judgement. UK marketing authorisations were subsequently withdrawn.

The UK Advisory Council on the Misuse of Drugs reported in 2026 that carisoprodol remained unlicensed in the UK, with the last licence cancelled in 2012. The report concluded that there were no legitimate current uses in UK human or veterinary medicine.

The UK Government accepted a recommendation to add carisoprodol to Class C and Schedule 4 Part 1, but said implementation would occur when parliamentary time allowed. Therefore, it should not be described as a UK-licensed medicine or an established UK treatment.

Do not use claims such as:

• MHRA-approved Soma
• UK-approved carisoprodol
• Licensed UK muscle relaxant
• Safe UK pain medicine
• Guaranteed genuine UK Soma
• Available without medical review

What Has Carisoprodol Been Used for Elsewhere?

Outside the UK, carisoprodol 350mg has been authorised in some countries for short-term relief of acute, painful musculoskeletal conditions in adults. The medicine is generally intended to be used with rest, physiotherapy and other supportive measures rather than as a stand-alone solution.

Carisoprodol 350mg should not be presented as treatment for every type of pain. It does not correct a torn muscle, damaged joint, slipped disc, infection, fracture, inflammatory disease or nerve injury.

Musculoskeletal pain may be linked with:

• Muscle strain
• Sprain
• Sudden lower-back pain
• Soft-tissue injury
• Poor posture
• Repetitive physical work
• Sports injury
• Another underlying condition

A healthcare professional should first determine whether symptoms require self-care, physiotherapy, a licensed medicine, imaging, urgent assessment or specialist treatment.

How Does Carisoprodol Affect the Body?

Carisoprodol acts on GABA-related pathways within the central nervous system. Soma Pain 350mg may therefore produce muscle relaxation, sedation, drowsiness and reduced coordination rather than acting directly on an injured muscle.

Carisoprodol is converted to meprobamate in the body. Meprobamate has a longer-lasting sedative effect and contributes to dependence and overdose concerns.

The medicine may begin affecting alertness relatively quickly and can therefore impair driving, balance, judgement and the safe use of tools or machinery.

Soma Pain 350mg Is Not a Sleeping Pill

The current live page uses sleeping-pill tags and contains wording about taking the medicine at sleep onset. This is misleading.

Soma Pain 350mg is not an authorised insomnia treatment in the UK. Drowsiness is an adverse central nervous system effect, not a reason to use carisoprodol for sleep.

Using a sedating medicine simply to force sleep can increase the risk of:

• Excessive sedation
• Falls
• Memory problems
• Dependence
• Withdrawal
• Breathing suppression
• Accidental overdose

People with insomnia should receive sleep-specific assessment rather than using an unlicensed muscle relaxant.

Main Safety Risks

Carisoprodol can affect the brain, breathing and coordination. Reported harms include:

• Drowsiness
• Dizziness
• Poor coordination
• Confusion
• Reduced alertness
• Partial amnesia
• Agitation
• Tremor
• Involuntary movements
• Respiratory depression
• Dependence and addiction
• Withdrawal symptoms
• Coma in severe overdose
• Death in very high-dose or mixed-drug overdose

The likelihood of serious harm rises when Soma Pain 350mg is combined with alcohol, opioids, benzodiazepines, gabapentinoids or other sedating substances.

Alcohol and Carisoprodol

Alcohol should not be combined with Soma Pain 350mg. Both substances can suppress the central nervous system.

The combination may cause:

• Extreme sleepiness
• Poor judgement
• Falls and accidents
• Memory loss
• Slow or shallow breathing
• Difficulty waking
• Collapse
• Coma
• Overdose

A person may appear to be sleeping while experiencing dangerous respiratory depression. Emergency medical help is required when breathing is slow, the person cannot be awakened or consciousness is reduced.

Opioids, Benzodiazepines and Other Sedatives

Soma Pain 350mg can become especially dangerous when combined with opioid painkillers or benzodiazepines.

Opioids include:

• Codeine
• Dihydrocodeine
• Tramadol
• Tapentadol
• Morphine
• Oxycodone
• Fentanyl
• Methadone

Benzodiazepines include diazepam, alprazolam, clonazepam, lorazepam and temazepam.

Carisoprodol, an opioid and a benzodiazepine all depress the central nervous system. Taking them together can greatly increase the risk of respiratory failure, coma and fatal overdose.

For related education, read what is tramadol and the Tapentadol safety guide.

Dependence, Addiction and Withdrawal

Repeated Soma Pain 350mg use can lead to tolerance and physical dependence.

Tolerance means that the same amount produces a weaker effect over time. This can lead a person to increase the amount without medical approval.

Dependence means the body has adapted to carisoprodol or its metabolite. Stopping after prolonged use may trigger withdrawal.

Possible withdrawal symptoms include:

• Anxiety
• Insomnia
• Irritability
• Tremor
• Sweating
• Muscle twitching
• Nausea
• Hallucinations
• Confusion
• Seizures in severe cases

Soma Pain 350mg should not be stopped suddenly by someone who has been using it regularly or in high amounts. That person should seek medical advice for safe assessment and support.

Overdose Warning

An overdose involving Soma Pain 350mg can cause central nervous system depression, confusion, abnormal movements, respiratory failure, coma and death.

Risk is higher when:

• More than the intended amount is taken
• Several tablets are taken together
• Alcohol is involved
• Opioids are involved
• Benzodiazepines are involved
• Another sedating medicine is involved
• The person has breathing or liver problems
• Tablets come from an unverified source

Call emergency services if someone has slow breathing, cannot be awakened, collapses, has a seizure or is suspected of taking an overdose. Do not make the person vomit unless emergency professionals instruct you to do so.

Counterfeit and Product-Identity Risks

The current page title says Soma Pain 350mg, but the SKU, tags and existing description repeatedly refer to 30/500mg, 500mg and other inconsistent strengths. This creates a serious product-identity problem.

Before any medicine page is published, the website should verify:

• Exact active ingredient
• Exact strength
• Whether it is a single-ingredient or combination tablet
• Manufacturer
• Country of authorisation
• Marketing-authorisation number
• Pack size
• Batch and expiry details
• Genuine patient leaflet
• Laboratory and supply-chain documentation
• Exact image matching the supplied pack

Soma Pain 350mg must not be described using information for a 500mg or 30/500mg product. Incorrect strength information can cause dangerous medicine errors.

Who Should Seek Urgent Medical Assessment?

Pain needs urgent assessment when it follows a major accident or is accompanied by:

• New weakness or paralysis
• Loss of bladder or bowel control
• Numbness around the groin
• Chest pain
• Difficulty breathing
• High fever
• Severe abdominal pain
• A swollen, hot or red joint
• Sudden severe headache
• Confusion
• Loss of consciousness
• Suspected fracture

Soma Pain 350mg should never be used to delay urgent assessment of serious symptoms.

Safer UK Pain and Muscle-Spasm Assessment

Because carisoprodol is unlicensed and not considered to have a legitimate routine UK use, patients should discuss licensed alternatives with a GP, pharmacist, physiotherapist or pain specialist.

Assessment may include:

• Identifying the cause of pain
• Checking for nerve or spinal symptoms
• Reviewing work and movement patterns
• Assessing current medicines
• Considering physiotherapy
• Reviewing licensed pain relief
• Treating inflammation where appropriate
• Addressing sleep, stress and activity levels
• Planning follow-up and recovery goals

For broader education, visit the Pain Killers category and read the co-codamol safety guide.

Frequently Asked Questions

What is Soma Pain 350mg?

Soma Pain 350mg is presented as a tablet containing 350mg of carisoprodol, a centrally acting muscle relaxant with sedative effects.

Is Soma Pain 350mg licensed in the UK?

No current UK marketing authorisation was verified. Official UK evidence states that carisoprodol is unlicensed and that its UK marketing authorisations were withdrawn.

Is carisoprodol a controlled drug in the UK?

The latest official review found that it was not yet controlled under the Misuse of Drugs Act, but the UK Government accepted a recommendation to classify it as Class C and Schedule 4 Part 1. Current legislation should be checked before making any legal-status claim.

Can Soma Pain 350mg be used as a sleeping tablet?

No. It is not an authorised UK insomnia medicine. Sedation is a risk rather than a reason to use it for sleep.

Can Soma Pain 350mg be taken with alcohol?

No. Alcohol can greatly increase sedation, impaired judgement, breathing suppression, coma and overdose risk.

Can carisoprodol be combined with tramadol or tapentadol?

This combination can greatly increase central nervous system and breathing depression. It should not be used without direct medical supervision.

Can carisoprodol cause dependence?

Yes. Prolonged or repeated use is associated with tolerance, dependence, addiction and withdrawal.

Is Soma Pain 350mg suitable for long-term pain?

No. In countries where carisoprodol has been authorised, it has been limited to short-term treatment of acute musculoskeletal discomfort. It is not an established long-term pain treatment.

Should the current product page offer Soma Pain 350mg for sale?

The safest UK approach is to disable purchasing and use the URL only for factual safety information, or remove it from the shop after professional regulatory review.

Final Thoughts

Soma Pain 350mg contains carisoprodol, a sedating muscle relaxant associated with dependence, impaired coordination, overdose and dangerous interactions. UK marketing authorisations were withdrawn, and official UK evidence states that carisoprodol remains unlicensed with no legitimate routine use in UK human or veterinary medicine.

The page should not encourage unrestricted purchase, customer-selected quantities or use as a sleeping tablet. It should provide clear safety information and direct readers towards assessment for licensed UK treatment options.

Anyone currently using Soma Pain 350mg should avoid alcohol and unapproved sedatives, should not drive when impaired, and should seek urgent help for slow breathing, collapse, seizures or difficulty waking.